News for 'life sciences'

Modi embarks on historic US visit, says this before departure

Modi embarks on historic US visit, says this before departure

Rediff.com20 Jun 2023

Modi said this 'special invitation' from President Joseph Biden and First Lady Jill Biden for a state visit is a reflection of the vigour and vitality of the partnership between the democracies.

Deepa Gahlot's Top Web Series of 2022

Deepa Gahlot's Top Web Series of 2022

Rediff.com29 Dec 2022

Stories of rural India, campus capers, realistic family dramas and urban romance that are no longer picked up by film-makers, find their way to the Web, and the viewing experience is richer for the variety available.

Romance Meets Avatar On OTT This Week

Romance Meets Avatar On OTT This Week

Rediff.com31 Mar 2023

It's raining sequels and true stories on OTT this week. Sukanya Verma lists everything you can watch.

Unapologetically Indian: Make Way For Vaishali S

Unapologetically Indian: Make Way For Vaishali S

Rediff.com13 Jun 2023

This star designer who has now found an audience on foreign shores, all thanks to her minimalistic style, and worship of Indian fabrics.

India-Australia relations enter T-20 mode, says Modi on strengthening ties

India-Australia relations enter T-20 mode, says Modi on strengthening ties

Rediff.com24 May 2023

Modi and Albanese also reiterated their shared ambition for an early conclusion of the ambitious Comprehensive Economic Cooperation Agreement (CECA) that is expected to significantly expand bilateral trade ties.

The Elephant Who's A TV & SM Star

The Elephant Who's A TV & SM Star

Rediff.com8 Jun 2023

As media phenomenon, Arikomban is in a different league. Efforts to capture the elephant were telecast live. Local three-wheeler drivers started a fans association for the pachyderm. A film has now been announced based on Arikomban's life.

Why Murthy chose Pravin Rao as Infosys COO

Why Murthy chose Pravin Rao as Infosys COO

Rediff.com13 Jun 2014

Pavin Rao, a 28-year company veteran, to be second-in-command at Infosys.

China making virus deadlier than Covid in Pakistan: Report

China making virus deadlier than Covid in Pakistan: Report

Rediff.com6 Nov 2022

According to various global media reports, China is creating Covid-like pathogens in Pakistan that have the potential of causing virus contamination on a scale far higher than Covid.

54 dead in Manipur violence; govt appeals for calm

54 dead in Manipur violence; govt appeals for calm

Rediff.com6 May 2023

Security presence which has been bolstered by flying in more army troops and rapid action force and central police forces was clearly visible at all major areas and roads.

US can declare 'independence' from China with India's help: Vivek Ramaswamy

US can declare 'independence' from China with India's help: Vivek Ramaswamy

Rediff.com27 Aug 2023

He is currently on a two-day swing to the crucial State of Iowa. On January 15, Iowa would kick off the 2024 Republican presidential primary season.

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Rediff.com2 Oct 2018

He is the first MD Anderson scientist to receive the world's most preeminent award for outstanding discoveries in the fields of life sciences and medicine.

10 ways in which Modi changed my life for the better

10 ways in which Modi changed my life for the better

Rediff.com8 Apr 2019

Syed Firdaus Ashraf lists 10 ways in his life has improved under the first Modi Sarkar.

Will India Win The New Space Race?

Will India Win The New Space Race?

Rediff.com19 Jul 2023

India is attempting to soft-land a rover on the moon and will attempt, at some point next year hopefully, sending humans into orbit. All of this makes an exciting time for space around the world, notes Aakar Patel.

As son joins BJP; Antony says pained by decision: Cong likens him to Judas

As son joins BJP; Antony says pained by decision: Cong likens him to Judas

Rediff.com6 Apr 2023

Antony, who headed the digital media cell of the Kerala Pradesh Congress Committee, slammed the Congress leadership for working for a "single family" instead of working for the country.

IPOs Mop Up Record Rs 1.19 Trillion

IPOs Mop Up Record Rs 1.19 Trillion

Rediff.com27 Dec 2021

Of the 59 IPOs for which the data is available, 36 IPOs received mega responses of more than 10x (of which, six IPOs more than 100x), while eight IPOs were oversubscribed more than 3x.

63 IPOs mop up record Rs 1.18 lakh crore so far in 2021

63 IPOs mop up record Rs 1.18 lakh crore so far in 2021

Rediff.com23 Dec 2021

The primary issue market has hit an all-time high with 63 corporates raising Rs 1,18,704 crore through main-board initial public offerings (IPOs) so far in 2021, which is nearly 4.5 times more than the Rs 26,613 crore raised through 15 issues in 2020 and almost double of the previous best of Rs 68,827 crore in 2017, according to a report. Pranav Haldea, managing director of Prime Database Group, said the IPO frenzy was driven by new-age loss-making technology start-ups along with strong retail participation, and the resultant massive listing gains were the key highlights of the year. Another highlight was only 51 per cent or Rs 103,621 crore of the total Rs 202,009 crore was fresh capital raising and the remaining Rs 98,388 crore were offers for sale.

Delhi terror suspects hired to kill rightwing leaders: Police

Delhi terror suspects hired to kill rightwing leaders: Police

Rediff.com17 Jan 2023

The Delhi police had earlier said it arrested two 'suspicious' men and recovered two hand grenades from their house in the Bhalswa Dairy area of Jahangirpuri.

Watch The Best Of Satyajit Ray On OTT

Watch The Best Of Satyajit Ray On OTT

Rediff.com2 May 2023

Had he not taken his final curtain call on April 23, 1992, Satyajit Ray would still, undoubtedly, have been making movies.

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Rediff.com10 Oct 2020

Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.

Nature Like Never Before

Nature Like Never Before

Rediff.com28 Nov 2023

Extraordinary award-winning photographs from more than 20,000 images from all over the world.

Why BJP In Karnataka Is Not In Good Health

Why BJP In Karnataka Is Not In Good Health

Rediff.com29 Mar 2023

'There is a conscious move by the BJP to distance itself from the current state leadership.'

'We could make mincemeat of the Pakistanis'

'We could make mincemeat of the Pakistanis'

Rediff.com5 Dec 2023

'My adrenalin kicked in and the happiness returned! It was time to go in for the kill again.' IAF Veterans Group Captain Dilip Kumar Dass tells Air Commodore Nitin Sathe about how the IAF decimated tanks in the famous Battle of Longewala.

Govt places order for 11 mn doses of Serum vaccine Covishield

Govt places order for 11 mn doses of Serum vaccine Covishield

Rediff.com11 Jan 2021

Dispatch of the vaccine is likely to start by early Tuesday morning, sources said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210.

'Nitish, Mamata, Stalin Don't Know India'

'Nitish, Mamata, Stalin Don't Know India'

Rediff.com7 Sep 2023

'Does anyone understand India?' 'Does anyone have a larger perspective for India as a whole?' 'Today we have rulers who do not understand the ruled.'

Oscar Winners On OTT This Week

Oscar Winners On OTT This Week

Rediff.com17 Mar 2023

Crime, climate change and cool Oscar winners dominate the OTT menu this week.

A Beginner's Guide To K-Drama

A Beginner's Guide To K-Drama

Rediff.com25 Apr 2023

It's addictive. It's entertaining. It's gorgeous. Once bitten by the K-drama bug, there's no going back.

'This Oscar journey is for all of South Asia'

'This Oscar journey is for all of South Asia'

Rediff.com11 Mar 2022

'How is it to live in a place that does not have electricity or a telephone connection, where people do not have any concept of what the world is beyond the mountains?'

Oscar Winner. Love. Superheroes. Swansongs.

Oscar Winner. Love. Superheroes. Swansongs.

Rediff.com1 Apr 2022

Sukanya Verma feels there's much to look forward on OTT this week.

4 Habits To Keep Your Heart Healthy

4 Habits To Keep Your Heart Healthy

Rediff.com9 Nov 2022

Food (ahara) and lifestyle (vihara) have a major impact on the health of your heart.

Hapur blast: Toll rises to 13, two booked for culpable homicide

Hapur blast: Toll rises to 13, two booked for culpable homicide

Rediff.com5 Jun 2022

The police have booked two persons for culpable homicide in the incident.

Adi Godrej: Parmeshwar's life is a big triumph

Adi Godrej: Parmeshwar's life is a big triumph

Rediff.com13 Oct 2016

'She adds value to life in many commendable ways. Apart from her many contributions to our consumer products business and Godrej Properties, she dedicates her energies and resources to charity, to philanthropic causes and most of all how she has managed her time as a wife, mother and entrepreneur brilliantly,' says Adi Godrej.

Meet few tech titans who gave away billions in charity

Meet few tech titans who gave away billions in charity

Rediff.com2 Dec 2015

Mark Zuckerberg's pledge on Tuesday to give away most of his Facebook shares, a roughly $45 billion fortune, helps cement his role as one of Silicon Valley's most generous donors.

Super 30 founder invited to speak at German university

Super 30 founder invited to speak at German university

Rediff.com24 Nov 2015

Anand will also interact with the Indian and German students at the Technical University of Chemnitz.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

Life lessons from the amazing Ruskin Bond

Life lessons from the amazing Ruskin Bond

Rediff.com19 May 2018

On his 84th birthday, the much loved author shares his latest thoughts.

8 Tips To Crack The Armed Forces Entrance Exam

8 Tips To Crack The Armed Forces Entrance Exam

Rediff.com27 Jun 2023

All work in the armed forces is team work. One has to deal with people all the time -- at work, play and even during war, advises IAF Veteran Air Commodore Nitin Sathe.

Mrinalini Sarabhai transformed Gujarat's cultural life

Mrinalini Sarabhai transformed Gujarat's cultural life

Rediff.com23 Feb 2016

Ahmedabad's cultural scene would not have gone beyond the garba, but for Mrinalini Sarabhai's pioneering efforts.

India among fastest growing FDI sources for USA

India among fastest growing FDI sources for USA

Rediff.com29 Jun 2015

India is one of the fastest growing FDI sources for the United States with investors from the country more interested in US' aerospace and textile sectors.

Kalam ideal representation of Indo-Islamic culture, lauds Kovind

Kalam ideal representation of Indo-Islamic culture, lauds Kovind

Rediff.com19 Jul 2022

Addressing the fourth APJ Abdul Kalam Memorial Lecture at the Rashtrapati Bhavan auditorium in New Delhi, Kovind said that "every Indian is proud of that great son of the country."

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.